Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
aTyr Pharma, Inc. (NASDAQ: ATYR)
ATYR Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-33.80%
Analyst Rating:
BUY
Analyst Forecast (1yr):
400%
ATYR Stock Analysis
ATYR
PE Ratio:
ATYR
PEG Ratio:
Not Available
ATYR
Forward EPS Growth (12 month):
0.00%
ATYR
PS Ratio:
265.9
ATYR
PSG Ratio:
Not Available
ATYR
Forward Revenue Growth (12 month):
0.00%
ATYR Articles
No data was found